• broken image

    Delivering Innovations to Patients In Need

    Innovations in drug delivery systems

  • Discover Pleryon

    Pleryon is a drug delivery platform company dedicated to improving the standard of living across the global community by developing programs utilizing advanced drug delivery technologies. Pleryon's platform is supported by pillar technologies covers a broad spectrum of molecules and therapeutic areas.

  • Versatile

    Cargo Scale

    from small molecules to nucleic acid

    Broad

    Biological Scale

    from subcellular to tissue level

    Tunable

    Time Scale

    from hours to
    months
  • background image
    background image
    background image
    background image
    background image
  • Meet Members of Pleryon

    broken image

    Yu YU, Ph.D.

    Cofounder, Chairman of the Board and CEO

     
    Dr. Yu Yu is an inventor and entrepreneur in drug delivery and biomaterial. He has over 14 years experience in biomaterials innovations. He is the key inventor for more than 10 invention disclosures and filed for more than 40 patent applications with inventions licensed to multiple companies. He also has published 11 research articles with more than 320 citation and a hi-index of 9.
    Dr. Yu received his BSc in Biology and PhD in Bioengineering (Laboratory of Ying Chau) from the Hong Kong University of Science and Technology (HKUST), and was awarded Overseas High-Caliber Personnel by Shenzhen government.
    broken image

    Prof. Ying CHAU, Ph.D.

    Cofounder, Board member and consulting scientist

     
    Prof. Ying Chau is a leading expert in drug delivery and biomaterials in China. She is a Professor of Chemical and Biological Engineering and Director of Bioengineering Program at the Hong Kong University of Science and Technology. She is also the Vice Chairman of Hong Kong Biotech Association (HKBIO). Prof. Chau has more than 25 years academic and industry experience, and has published 60 research articles with more than 2000 citations.
    Prof. Chau received her B.S from Cornell University, M.S from University of Pennsylvania, and PhD from MIT (Laboratory of Robert Langer).
    broken image

    Andrew LUK, Ph.D.

    Executive Director of Global Alliance

     
    Dr. Andrew Luk brings 27 years medtech industry experience to Pleryon. Before joining Pleryon, Dr. Luk held senior positions in CooperVision Inc. and Johnson & Johnson, where he had extensive product development, technology translation and collaborative alliance experiences. He has been involved in advancing innovative products from concepts to clinical trials (including regulatory submission) for a variety of drug delivery, drug-device combination products and medical devices, with excellent knowledge in quality assurance and regulatory compliance. Dr. Luk received his PhD in Chemical Engineering from University of Delaware.
    broken image

    Zhexun SUN, Ph.D.

    Director of Innovation and Chemistry

     
    Dr. Sun Zhexun has over 10 years academic experience in biotherapeutic polymer design and engineering. Before joining Pleryon, he is a postdoctoral fellow at Cornell University, designing innovative polymers for orthopedics and ophthalmic applications.
    Dr. Sun received his B.S from Wuhan University, M.S from Rutgers University and Cornell University, and PhD from Cornell University (Laboratory of David Putnam). He received Cornell Engineering Scale-up Award and was awarded Overseas High-Caliber Personnel by Shenzhen government.
  • Contact us

    broken image
    Longhua and HK-SZ Collaboration Zone
    broken image
    Zhangjiang High Tech Park (JLABS@Shanghai)
    broken image
    contact [at] pleryon.com